Ignite Creation Date:
2024-05-06 @ 4:21 PM
Last Modification Date:
2024-10-26 @ 2:08 PM
Study NCT ID:
NCT04957823
Status:
COMPLETED
Last Update Posted:
2024-02-29
First Post:
2021-07-03
Brief Title:
Irisin Expression and Gene Polymorphism in Type II Diabetic Patients With and Without CAD
Sponsor:
Sohag University
Organization:
Sohag University
Study Overview
Official Title:
Serum Irisin Level FDNC5 Genetic Polymorphism Can Predict the Presence Severity of Coronary Artery Disease in Patients With Type II DM
Status:
COMPLETED
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CAD
Brief Summary:
This is an observertional study aimed at Study the association between the level of irisin expression and Fibronectin Type III Domain Containing 5 FDNC5 gene polymorphism and the presence and severity of coronary artery disease in patients with Type II DM
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None